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Abstract
The effects of prenatal exposure to many prescription medications are well known.
However, little is known about the long term side effects early exposure to medications used
to treat pain and sedate have on growth and development. This paper explores the long-term
effects of postnatal exposure to prescription medication. The potential effects are applied to
physical, cognitive, and social-emotional development as well as the overall health of an
infant. Additionally, the options of the use of commonly used analgesics and sedatives are
compared to other pain management options. Research surrounding long-term effects of
early exposure to pain and generalizations/recommendations are explained.
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Chapter One: Introduction
Problem Statement
Many reasons exist for infants to be hospitalized after birth. During a hospital stay,
infants can receive a myriad of medications ranging from Tylenol to Morphine. Some of the
drugs that are given to infants are those that are also given to adults. These prescription
drugs are approved for use, so there is no question as to whether the drugs are effective.
However, one question that still remains is: how does exposure to prescription drugs such as
morphine or valium during infancy effect growth and development of the child? Growth and
development of a child covers many areas. The intent of this thesis is to determine the
effects of prescription drugs, if any, on cognitive, physical, social-emotional development as
well as development of overall health.
In some cases, infants are diagnosed with neonatal abstinence syndrome (NAS).
“Two major types of neonatal abstinence syndrome are recognized: neonatal abstinence
syndrome due to prenatal or maternal use of substances that result in withdrawal symptoms
in the newborn and postnatal neonatal abstinence syndrome secondary to discontinuation of
medications such as fentanyl or morphine used for pain in the newborn” (Hamdan, 2012,
para. 1). A diagnosis of NAS can include a variety of complications in behavioral and
physiological development.
Importance of the Problem and Rationale for the Study
The first four years of development are some of the most important in a person’s life
in terms of development. What happens to a child’s growth and development if there is an
interruption in typical development? For example, infants who are hospitalized and exposed
6

to prescription drugs may also experience a disruption in their physical development due to
the hospital stay. While some infants require further intervention to assist in their
development, many do not. Not all infants show signs of delays right away, but what if there
are issues down the road? The infant may grow into a toddler who appears to be typically
developing. It is vital for the development of the child to be as informed as possible of
potential long term effects of prescription drugs.
Background of the Problem
There are instances when infants require medical procedures that would cause them
pain. However, without the use of drugs such as morphine or fentanyl, the effects could be
detrimental to the development of the infant. “The mounting of a surgical stress response
results in catabolic responses, including glycogenolysis, gluconeogenesis and lipolysis during
the perioperative period. These catabolic responses, when unmodulated by medical
intervention, may have a detrimental effect on the clinical course of a neonatal surgical
patient. Adverse circulatory and respiratory events are also more likely during the
postoperative course of neonates who have had inadequate interventions to minimize stress
response. These responses include tachycardia, systemic hypertension, pulmonary
hypertension and neuronal excitotoxicity. Furthermore, inadequate treatment of pain in
neonates may have implications that extend beyond the neonatal period, including longlasting changes in pain behavior” (El Sayed, Taddio, Fallah, De Silva, & Moore, 2007, p.
444). Given the detrimental effects prolonged pain could cause, doctors and surgeons are left
with no choice but to medicate even the youngest patients. One of the difficulties in this
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situation is that most drugs are evaluated and approved for adults, not children, let alone
infants.
Prescription drugs are commonly used in pediatrics for children aged between 0 and
18 years for the management of various disorders. “In the United States, pediatric patients,
on average, visit a physician's office almost twice a year and marketed drugs are prescribed
in up to 60% of these visits. Despite the therapeutic benefits of prescription drugs, their use
can be associated with potentially serious side-effects. For example, a systematic review
found that 9.5% of pediatric patients developed adverse drug reactions after receiving drug
treatment during their hospital stays and 12% of these reactions were life threatening. Given
the potential for serious harm that prescription drugs may cause, adequate assessments of
drug safety in pediatrics have become central to the overall health of this vulnerable
population” (Luo, Doherty, Cappelleri, & Frush, 2007, p. 2607). Although commonly used
prescription drugs are not approved for use by pediatric patients, it does seem to be common
practice.
Another difficulty that medical professionals face is the assessment of pain of an
infant. Unlike older children and adults, infants cannot verbally express the pain they are in;
therefore they have to rely on doctors, nurses, and family members to determine the level of
pain of the infant. “In order to assess the effectiveness of medical therapy, pain must be able
to be evaluated. However, there is no objective pain meter. The perception of pain includes
a sensory component, involving neural pathway activation in response to noxious stimuli,
and an effective response, which involves behavioral and cognitive factors” (Rosen &
Dower, 2011, p. 245). Given that information, there are many pain scales used to measure a
8

patient’s level of pain. Two common pain scales are the CHIPPS (Children’s and Infants’
Postoperative Pain Score) and CRIES (Crying, Requires Increased oxygen administration,
Increased vital signs, Expression, Sleeplessness) (Gitto et al., 2011, p. 929). Each of these
scales measure pain based on observations of adults rather than communication from the
patient. As indicated in the full name of each scale, medical vital signs do play a role in pain
assessment. Nurses and doctors monitor respiratory rate, heart rate, as well as facial
expressions to determine whether or not a child is in pain. One issue with scales such as
CHIPPS and CRIES is that they rely on observations, not self-report so the pain may be
underestimated (Berde & Sethna, 2002). In order to meet the pain management needs of
infants, medical professionals need to consult the family of the patient in addition to
monitoring vital signs.
The research indicates that prolonged or even early exposure to pain could alter the
nociceptive circuits (sensory neurons that communicate with the brain and spinal cord) in the
brain, creating over or under reaction to pain. Research of specific drugs commonly used as
analgesics or sedatives also provides information regarding potential harmful side effects.
This information places medical professionals and families in a bind. Should the infant be
untreated and therefore exposed to the potentially harmful effects of pain? Or, should the
infant be medicated and exposed to the potential side effects of drugs, or the potential of
being over medicated unnecessarily? This is the predicament that must be dealt with when
treating infants. The research states that an individual pain management plan should be
created using both pharmacological intervention as well as non-pharmacological strategies.
“Optimal pain management should include a combination of prevention, pharmacologic
9

strategies, and non-pharmacologic approaches, or some combination of these techniques”
(Walter-Nicolet, Annequin, Biran, Mitanchez, & Tourniaire, 2010, p. 356).
There are several different non-pharmacological pain management strategies that
have been found to be effective. “Non-pharmacologic treatments may be beneficial in many
ways, including decreasing anxiety and reducing the need for opiates or other analgesics”
(Rosen & Dower, 2011, p. 244). Several of the most common pain management strategies
that do not include medication involve a family member. By involving the family, stress on
the infant and family could be lowered. The most common non-pharmacological strategies
are: kangaroo care (skin-to-skin contact), swaddling, non-nutritive sucking, rocking or
holding, distraction through the use of toys, talking, or music. Infants can also be given a
serum of glucose or sucrose. It is thought that the sweet taste has a psychological effect on
the infant (Rokyta & Fricova, 2012). All of these strategies reduce the pain the infant feels
during a painful procedure like a heel prick. However, for infants who have chronic or postoperative pain, a combination of pain management strategies is most likely needed.
Additionally, hospitals typically have a team in place to assist children and families
with decisions about creating pain management plan, reducing anxiety, and providing
opportunities to participate in various activities. Child Life Specialists assist the patient by
providing medical play opportunities to ease anxiety surrounding medical procedures as well
as art and music therapy to distract patients and ease pain (Regents of the University of
Michigan, 2013).
When it comes to pain management for infants, analgesics and sedatives are often
necessary in order to keep the infant comfortable. While non-pharmacological strategies do
10

alleviate pain or distract the patient, pharmacological intervention is often a necessity
(Tobias, 2005). Drugs that are commonly used to treat infants can be broken into a few
categories based on the way they work. The World Health Organization (WHO) has created
lists of the most commonly used drugs in each category. Opioids are probably the most well
known drugs used as analgesics. This category contains morphine, fentanyl, and methadone.
Not only are opioids the best known category, they have also been studied the most, and
therefore are considered tried and true. Opioids impact the central nervous system which
makes them a drug of choice for moderate to severe pain. Benzodiazepines are another
category of drugs used for pain management in infants. The two most common
benzodiazepines are Midazolam and Lorazepam. This category of drugs depresses the
central nervous system, allowing the infant to become relaxed and possibly drowsy.
Barbiturates are yet another category of drugs proven to alleviate pain. The most common
drugs in this category are Phenobarbital, Thiopental, and Ketamine. Ketamine, most
commonly used in the NICU/PICU. Barbiturates affect the body by depressing nerve activity
in large muscle groups of the body. Given the potential for dependency and unpredictability
of patient reactions, barbiturates are not the first choice for pain management in infants.
Finally, non-steroidal anti-inflammatory drugs (NSAIDs) are the final choice for pain
management. The most common NSAIDs are Acetaminophen, Ibuprofen, Naproxen, and
Ketrolac. “NSAIDs have well known analgesic, antipyretic and anti-inflammatory effects
(Gazarian & Graudins, 2006, p. 71). While all of these drugs have been found to be effective
in pain management for infants, many are still being used “off-label” as their effects on
infants and children have not been studied.
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There appears to be a gap in knowledge and research regarding the effects of
prescription medication on pediatric patients. This gap includes current studies of short term
and long term effects on children. “Over the last decades, it was believed there was a need to
protect children against research. There is now an increasing notion that they also have a
right to benefit from research that keeping them systematically out of the research process
amounts to withholding from them the potential benefits of pharmaceutical progress, and that
exposing them continuously in daily practice to medicines not properly tested in their age
group is ethically challenging. This has led to the new paradigm that children need protection
through, not against, research and clinical trials” (Rose, 2009, p. 57). A shift in thinking of
clinical drug trials may give way to accurate information about the effects prescription drugs
have on pediatric patients. How does this shift affect regulations and approval by the Food
and Drug Administration?
Statement of Purpose
Although the medical and pharmaceutical communities are changing, a gap still
remains in research involving prescription drug use among pediatric patients. The purpose of
this study is to review and analyze current research on the effects of prescription drugs have
on human growth and development. Upon analyzing current research, a qualitative report
will be completed detailing findings in the areas of cognitive, physical, and social-emotional
development. Additionally, effects of prescription drugs on the overall growth and health of
a person who was exposed to prescription drugs in infancy. Once the findings have been
analyzed and reported, any trends or gaps in research will be added to the study. Finally,
areas and suggestions for further research will be discussed.
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Research Questions
While the focus of this study will be the long term effects of prescription drugs on
human growth and development, many other questions have arisen. As previously stated,
growth and development covers an array of areas. One area that may be affected is nutrition.
Does exposure to prescription drugs in infancy affect the overall nutrition of the infant? Are
they able to eat and therefore grow at a similar rate to those infants who were not exposed to
such drugs? Also, how does the hospitalization itself contribute to the infant’s growth and
development? Assuming that these questions can be answered with current research, an
additional question would be, how does or can the Food and Drug Administration use this
information?
Design, Data Collection, and Analysis
Through documentary research, a qualitative report will be written. As previously
stated, current research will be reviewed and analyzed. In order for research to be considered
current, it will have been published within the last decade. Any research reviewed and
analyzed with a publication date older than ten years had no conflicting research with a more
recent publication date. The literature that will be used in the study will be journal articles
that have been peer reviewed. Analysis of the literature will consist of determining the most
commonly used analgesics and sedatives in Neonatal Intensive Care Units. Additionally,
side effects of the most common drugs will be determined and applied to various stages of
development. The focus will be in the areas of cognitive, physical, and social-emotional
development. Effects of prescription drugs on the overall growth and health of a person who
was exposed to prescription drugs in infancy will also be discussed. Any additional research
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questions that can be answered will be incorporated into the findings or documented as an
area for future research. Trends and or gaps in research will also be included in the study.
Lastly, areas and suggestions for further research will be discussed.
Definition of Terms
Analgesic - Drug that relieves pain without impairing function (Merriam-Webster, 2013).
FDA - Food and Drug Administration
NICU - Neonatal Intensive Care Unit
NSAIDs - Non Steroidal Anti Inflammatory Drug
Sedative – Drug that helps calm (Merriam-Webster, 2013).
WHO - World Health Organization
Organization of Thesis
Chapter Two contains a literature review on the topics of pain, pain management,
drug development and use, and details of effects on development. This leads into Chapter
Three which summarizes the literature review as well as details the research process.
Chapter Four contains the main findings of the study, including areas for further research.
Finally, Chapter Five is a summary of the entire thesis.
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Chapter Two: Literature Review
Introduction
This chapter includes a discussion of the difficulties in determining the long term
effects of exposure to prescription medication in infancy. The chapter begins with an
explanation of how the Food and Drug Administration plays a role in which medications are
approved for use in infants, children, and adults. In addition, there is information regarding
the use of such medications whether they have been approved for use on children and infants
and the reasons why. This leads into the dilemma of whether or not to medicate children and
infants with unapproved medication or allow them to potentially suffer long term effects of
exposure to pain. Ultimately, the pros and cons of pain management through the use of
analgesics and allowing an infant to be in pain are detailed. Additionally, the efficacy and
side effects of the most commonly used drugs are discussed. Finally, typical infant
development is discussed and compared to development of an infant who was exposed to
drugs and how they may develop. Suggestions to support development are also included.
Theoretical Framework
There are many reasons for adults and children alike to be hospitalized. During a
hospital stay one would expect to receive some type of medication. Most people seem to
know that adult medications cannot usually be given to children, particularly infants.
However, it was not until 1992 that the Food and Drug Administration (FDA) began to
regulate the use of medications on pediatric patients (Buck, 2000, p. 95). The first regulation
of pediatric medications spurred other regulations that provided for pharmacological studies
on pediatric patients. From those regulations came more accurate labeling of drugs and the
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development of pediatric pharmacology units (Buck, 2000). Subsequently with all of the
progress in medication labeling and dosing the need emerged for longitudinal studies of
potential side effects and/or long term effects of such drugs. However, the administration of
drugs to pediatric patients has not changed greatly as most medications approved for
pediatric use are drugs that are rarely used on pediatric patients. Additionally, those drugs
that are commonly used for pediatric patients are not generally used for pediatric studies and
therefore not approved for pediatric use (Boots et al., 2007). The following chapter will
discuss additional FDA regulations in regards to pediatric patients, the balance between long
term effects of exposure to pain versus long term effects of exposure to prescription
medication, and any known long term effects of pain or medication exposure.
Synthesis of Research Literature
Role of Food and Drug Administration
Infants who survive traumatic events sometimes show signs of developmental delays
in several areas of development. The actual hospital stay and procedures are usually the
reason assumed for the delay in motor, cognitive, or nutritional development. However,
lasting effects of medications are not typically discussed. If infants and children are given
medication to which some adults develop a dependency or addiction, what about the long
term effects the same medication could have on the development of a child?
As important as knowing long term effects of medications are, longitudinal studies
involving pediatric patients are nearly non-existent. In the past few decades, the Food and
Drug Administration has passed several regulations involving medications for pediatric
patients. However, there are still several reasons why there are very few longitudinal drug
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studies of pediatric patients. “Before regulatory approval, all prescription drugs must go
through rigorously designed pre-marketing randomized clinical trials (RCTs) to ensure
efficacy and safety. Unfortunately, only about 20% of the drugs used to treat pediatric
patients in hospitals or in general practice have gained regulatory approval for pediatric use.
The other 80% either do not have an approved indication for pediatric use or are prescribed
outside of product label (‘off label’). The safety of using these drugs in the pediatric
population has not been well tested by pre-marketing RCTs and, consequently, little is
known about the potential side-effects that these drugs may cause to pediatric patients” (Luo
et al., 2007, p. 2608). It is a concern that there is little information regarding side-effects and
long term effects of prescription medication taken by infants and children.
Long Term Effects of Pain versus Effective Pain Management
“Pain produces suffering, fear, and vital inhibition. As individuals, we have a strong
urge to minimize the risk for and the suffering from pain. Therefore, moderate and severe
postoperative pain can and should be prevented or controlled safely and effectively in all
children whatever their age, severity of illness, or surgical procedures” (Messerer, Gutmann,
Weinberg, & Sandener-Kiesling, 2010, p. 879). Anyone who has undergone a surgical
procedure expects to feel some pain. However, adults and older children can describe the
feeling and location of the pain. Infants are different. “Another problematic aspect about
pain in children is the lack of a clear understanding about how children at different stages of
development may respond to pain (Turkoski, 2007, p. 194). Infants of all ages do
communicate to us, but often times their signals go unnoticed or are misread. “A gathering
body of animal and human evidence suggests that early pain has long-term consequences on
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the developing individual” (Ponder, 2002, p. 218). So again, the dilemma is deciding
between pain management and prescription drugs with potentially life altering side-effects.
“Chronic pain in children has a negative impact on the quality of life, resulting in
social and emotional consequences for both the child and the family (Messerer et al., 2010, p.
879). Children and infants who are in pain are often given an opioid to relieve their pain.
However, as previously mentioned, long term effects of prescription drug exposure has not
been widely studied. For the purpose of this study, only the most common types of
analgesics and sedatives will be discussed.
Effects of Pain versus Effects of Prescription Pain Medication
As previously discussed, there could be negative long term effects from exposure to
pain and prescription medications during infancy. As a family member or medical
professional, weighing the options for an infant would be difficult. There are pain
management options that provide the best of both worlds, less pain medication and less pain.
As mentioned in chapter one, there are pharmacological interventions as well as nonpharmacological strategies to lessen the pain an infant endures. “Pain has been shown to
evoke specific brain activity in the cerebral cortex starting at 24 weeks of gestation. Of
special concern is that this time period includes several critical developmental stages and
plasticity of certain nociceptive circuits can create long-term changes. Early experiences
with pain during these critical periods can be reflected in pain perception in adulthood.
Therefore, the period in which pain exposure begins is very important” (Rokyta & Fricova,
2012, p. 110). Knowing that early exposure to pain is key in the alteration of pain
recognition, medication seems to be a necessary component of pain management. None of
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the non-pharmacological strategies have been proven to completely alleviate pain, only
lessen through distraction.
As a parent of an infant in pain, the decisions regarding the best treatment for your
child are difficult to make and rely heavily on medical staff and their knowledge. It is safe to
assume that no parents want to see their child in pain. When it is necessary, infants are given
drugs that are typically reserved for adults. However, with the alleviation of pain could come
with some costs. All medications have side effects of one sort or another. The most
common pain management drugs are opioids. Along with opioids, benzodiazepines,
barbiturates, and NSAIDs are commonly prescribed as part of a pain management plan. All
of those drugs have potentially detrimental side effects. One side effect that all of these
drugs have in common is the potential for overuse. As previously mentioned, there is not an
objective way to assess pain that infants feel, as they cannot communicate verbally. With
that said the determination of when to administer a dose of medication is at the discretion of
medical staff. Additionally, the majority of these drugs are used “off-label,” which means
they have not been approved by the FDA for use on children. In the case of “off-label” use,
improper dosing is a concern, as there is no dosing information for children. Another
common issue with the use of any of the above categories of drugs is the potential for
interaction with other medications the infant may be given. Along the same line, specific
drugs must be avoided given the diagnosis of the patient. Many drugs are not suitable for
specific conditions.
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Each of the drug categories has its own unique list of potential side effects. Keep in
mind that these are side effects known for use of the medication in adults, the effects on
infants and children could be different.
Opioids: respiratory depression, nausea, vomiting, constipation, drowsiness, dizziness,
pruritis, muscle spasms, and urinary retention
Benzodiazepines: physical dependence, drowsiness, over-sedation, myoclonic jerking, and
respiratory depression.
Barbiturates: physical dependence, sedation, altered mood and behavior.
NSAIDs: adverse effects on the hepatic system, nausea, diarrhea, gastrointestinal ulceration
and bleeding, headaches, dizziness, fluid retention, and rashes.
(WHO, 2010) (Scottish Neonatal and Paediatric Pharmacists Group, 2010)
Most Common Pain Management Drugs
Opioids. “Opioids are widely used for analgesia and sedation in neonates. They
have potent analgesic effects, sedative but no amnesic or hypnotic effects, weak to moderate
effects on hemodynamic stability, and reversible adverse effects. Their adverse effects
include respiratory depression, bronchospasm, reduced gastrointestinal motility, urinary
retention, and pruritus” (Walter-Nicolet et al., 2010, p. 358). There are many types of
opioids used for pain management; this study will discuss only the most common types of
opioids.
“Morphine and fentanyl are the most commonly used opioids in the NICU” (WalterNicolet et al., 2010, p. 358). Since morphine and fentanyl are the most commonly used
opioids for pain management of neonates, there should be longitudinal studies of the long
20

term effects. However, there are very few studies of long term effects of either of these
medications. The majority of side-effects previously mentioned are short term effects.
Additionally, the majority of longitudinal studies that were found were conducted on preterm
infants, not full term infants. This poses a problem, as preterm infants may have other
factors that affect their development aside from effects of medications.
Benzodiazepines. “The benzodiazepines are anxietolytic drugs that have limited
analgesic effect but are commonly used in NICU’s to produce sedation, muscle relaxation
and provide amnesia (in older patients)” (Hall & Shbarou, 2009, p. 17). There is limited
research regarding the analgesic properties of benzodiazepines, but they are still a drug of
choice for pain management in infants. There are two commonly used benzodiazepines for
pain management of infants, midazolam and lorazepam. Typically, both midazolam and
lorazepam are used in combination with morphine to better control pain and provide more
effective sedation. While benzodiazepines are used in the NICU, they can have significant
side effects, the most common in myoclonic jerking, which is similar to convulsions created
in seizures. Additionally, benzodiazepines have the potential to cause respiratory depression,
excessive sedation, and at times hypotension (Hall & Shbarou, 2009).
Barbiturates. “Barbiturates are commonly used in neonates for sedation and
analgesic effects, despite a lack of evidence for pain relief” (Hall & Shbarou, 2009, p. 18).
The most common barbiturate is phenobarbital. Phenobarbital is widely known as a drug for
seizure control. However, there is evidence in animal studies of its analgesic properties.
Although there are animal studies indicating analgesic effects, there have been no studies in
regards to use with infants. Phenobarbital can cause some adverse reactions, most
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commonly, sedation, depression, insomnia, and altered mood or behavior. In addition to the
above side effects, there is the chance of physical dependence and severe adverse reactions
with many other commonly used drugs (WHO, 2010).
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). “NSAIDs are effective in
alleviating pain and inflammation in infants and children. They are generally well tolerated
when used for appropriate indications, in recommended paediatric doses, and with
consideration of relevant precautions” (Gazarian & Graudins, 2006, p. 71). NSAIDs are
unlike many of the other drugs previously discussed; some can be purchased over the counter
and used without a prescription. While NSAIDs are widely used, they do not offer the same
analgesic affects as opioids. In fact, the analgesic ability of NSAIDs has not been studied for
use in neonates. NSAIDs tend to take longer to take effect, last for a shorter duration, and
generally require higher doses than other analgesics (Gazarian & Graudins, 2006). As with
all other medication, there can be adverse effects. The most common side effects are adverse
effects on the hepatic system, nausea, diarrhea, gastrointestinal ulceration and bleeding,
headaches, dizziness, fluid retention, and rashes. Although it is assumed that NSAIDs like
ibuprofen have beneficial analgesic properties, some of the side effects have caused medical
professionals to use NSAIDs cautiously.
Other Commonly Used Drugs. “Ketamine is a dissociative anesthetic used for
anesthesia, analgesia and sedation” (Hall & Shbarou, 2009, p. 18). Although ketamine has
several uses, it is typically given for short durations for painful procedures and as
maintenance of anesthesia (WHO, 2010). Research indicates that the effects of ketamine are
still under investigation. Several animal studies imply there are neurodegenerative effects
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that could be caused by ketamine. However, there are no conclusive human studies
indicating one way or another the effects ketamine has on the human brain (Hall & Shbarou,
2009). Even though some effects of ketamine are questionable, many are not. Ketamine has
been shown to raise blood pressure and pulse rate, raise intracranial and intraocular pressure,
hypersalivation, increase muscle tone, in some cases alter mood and behavior (WHO, 2010).
The potential side effects of ketamine are what make its desired use short term. But, the
anesthetic, analgesic, and sedative properties make it a drug of choice even for infants.
Developmental Domains
Reasons for a hospital stay range from one day to many days. During that stay, the
patient may be exposed to many different medications including analgesics and sedatives.
Generally, a person is in the hospital to heal which requires rest. Imagine an infant “resting”
as they heal. During the first year of life infants are supposed to be active and curious. The
following sections detail three areas of development, physical, cognitive, and socialemotional.
Physical Development. Physical development requires movement and can be broken
into two categories, fine motor and gross motor. Fine motor means, “using hands to be able
to eat, draw, dress, play, write, and to do many other things” (Boyse, 2012, para. 2). For an
infant, fine motor skills are developed through manipulating objects, reaching for objects,
and interacting with family members. Gross motor involves, “using large groups of muscles
to sit, stand, walk, run, etc., keeping balance, and changing positions” (Boyse, 2012, para. 2).
Just as fine motor skills are developed through movement, so are gross motor skills.
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Cognitive Development. Similarly to physical development, cognitive development
depends on an infant interacting with their environment. Cognitive development refers to
“thinking skills, including learning, understanding, problem-solving, reasoning, and
remembering” (Boyse, 2012, para. 2). If an infant is sedated they are unable to interact with
their environment, family, or medical staff. In terms of cognitive development, by one
month of age an infant prefers to study human faces over other objects, can recognize the
smell of mother’s breastmilk, and recognizes some sounds and may turn in that direction
(American Academy of Pediatrics, 2013). By three months, a typically developing infant
should be able to look in the direction of a familiar sound like a voice, recognize their bottle
or breast, look in the direction of bright colors or lights, and respond to noise such as a rattle
(American Academy of Pediatrics, 2013). By six months, an infant should be able to add to
opening mouth for spoon and imitate familiar actions performed by caretakers (American
Academy of Pediatrics, 2013). In the same way that physical development is structured,
where each skill builds on the last, so is cognitive development. For example, if an infant is
not responding to familiar voices and studying their caretakers, they will not be able to mimic
familiar actions.
Social-Emotional Development. Social development and cognitive development are
closely related, specifically in infancy. Social emotional development can be described as,
“interacting with others, having relationships with family, friends, and teachers, cooperating,
and responding to the feelings of others” (Boyse, 2012, para. 2). If an infant is sedated or
constantly feeling ill from mediations, interactions will be limited and therefore social
emotional growth stunted. An infant who is one month of age typically prefers to study
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faces, tend to enjoy soft touches, and recognize and respond to some sounds. By three
months old, an infant generally calms when held or spoken to in a soft, familiar voice,
communicate through cooing or gurgling, cry or change expression to indicate hunger, pain,
or fear, and smile in response to others smiling. And, by the age of six months, an infant
should be babbling, recognize familiar faces, smile at self in mirror, scream, laugh, and
squeal (American Academy of Pediatrics, 2013). As with cognitive development, infants
need to interact in order to develop socially and emotionally.
Summary
Sitting by your child’s bedside during a hospital stay can be daunting on its own.
But, as you watch your child recover, you may begin to wonder about the effects of the drugs
to which your child has been exposed. Fortunately, the Food and Drug Administration has
begun to pass regulations that mandate labeling drugs for use in the care of infants and
children. The FDA also passed regulations making it possible for drug studies on children.
With the new regulations from the FDA, the hope is for more longitudinal studies on the
effects of prescription medication.
Conclusion
Although there have been many advances in the development and testing of drugs
for children, there is still progress to be made. There are a limited number of longitudinal
studies conducted on the effects of prescription drugs on infants and children. Recently, the
FDA has passed regulations that open the door for drug studies to be conducted using
children as subjects. This poses yet another issue in determining long term effects of
prescription drugs; who is going to volunteer their child for a drug study?
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The true long term effects of prescription drugs on children could also be difficult to
determine. Children who require such medication also may have had a lengthy hospital
delay due to an illness, surgery, or being born premature. All of these factors contribute to
the difficulty of determining whether long term effects are due to exposure to medication or
another factor.
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Chapter Three: Research Design
Introduction
The purpose of this study is to discover what research says about the longterm effects of exposure to prescription medication during infancy. A thorough literature
review was conducted. Through the literature review it was discovered that little is known
about the long-term effects of prescription drugs on the development of an infant. Given that
there is nearly no information regarding long-term effects, the study was refocused on shortterm, physiological effects that impact development. From there, the most commonly used
drugs in NICUs were identified. Once the drugs had been identified, the physiological
effects were then identified. In order to analyze the effects of the most commonly used
drugs, typical development in the first six months of life was researched. The impact of the
most commonly used drugs were then applied to development in the first six months of life.
Long-term effects were then related to the short-term effects on physiological development
of an infant.
This chapter contains a discussion of instrumentation of the study. The first section
explains the instrumentation. This is a qualitative study that was conducted through
documentary research. Next, data collection is discussed. Finally, the chapter concludes
with a presentation of data analysis.
Instrumentation
A qualitative approach was deemed the most effective way to approach this study by
gathering data through reviewing and analyzing current research. Through reading literature
related to medications administered to infants, side effects of those medications and
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developmental theory, it was possible to identify units for analysis which were used to
compare across categories and discover relationships between drugs, physiological effects,
and developmental milestones. This approach allowed for generation of hypotheses
grounded in data that related to possible impacts of medications on critical developmental
periods (Goetz & LeCompte, 1981). This was particularly important because little is known
or documented in the research about the effects of medication on the development of infants.
When completing qualitative research, the researcher generally observes, analyzes, and
interprets the information. In this case, there was no setting in which to observe and analyze.
Instead, documentary research was chosen. However, conducting the study through
documentary research limits the study by reviewing, interpreting, and analyzing data
collected by others.
The initial goal of this study was to determine what long-term effects, if any, are
experienced by people who were exposed to medication in infancy. Little to no information
was found regarding the long-term effects of exposure to prescription drugs on infant growth
and development. At that point, the questions that guided the study were reframed. There
are many drugs given to infants, so, in order to determine which medications to focus on, the
drugs most commonly used in the NICU needed to be determined. This led to the two most
common reasons infants are medicated, pain management and sedation. From there, the most
commonly used analgesics and sedatives were determined. Additionally, the short term side
effects of the most commonly used analgesics and sedatives were researched. The short term
side effects were then applied to stages of infant growth and development so that connections
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could be made to potential long term side effects. The majority of resources for this study
are from medical journals.
Articles relating to full-term infants who were hospitalized and exposed to
prescription medications were reviewed. The research focused on full-term infants based on
the fact that pre-term infants could have other complications that would make it more
difficult to determine whether long-term effects are from exposure to medication,
hospitalization, or complications from prematurity.
Research also led to discovery of the Food and Drug Administration’s role in the
use of drugs on pediatric patients. From the information on the FDA came many other
questions and articles; however, they strayed from the original research question and were
ultimately dismissed.
There were some topics not included in the study, due to time constraints and depth of
the study. Specific reasons for hospitalization were not considered as the symptoms or
recovery could add to the complexity of determining long-term effects of medication.
Medications that were excluded were those that are generally taken by adults and only
administered to children in extreme circumstances. Additionally, medications that were
discussed have the primary function of analgesia or sedative. There are many other
medications used in NICUs that are not primarily used for analgesia or sedation.
Data Collection
For the purpose of this study, data was collected through extensive literature review.
The majority of sources for this study were found via the Grand Valley State University
Library online system. Some of the search terms include: long-term effects of medications,
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most commonly used medications in NICUs, side-effects of prescription medications, and
infant development. Most of the sources relating to medication and side effects were
published in medical journals found on Medline and ProQuest Medical Library. The
majority of sources for information regarding specific medications and their side effects were
published in medical journals. Most of the journal articles were reviewed by peers in the
medical field. The information regarding child development was collected from websites
dedicated to the health and development of children. The websites the articles were obtained
from were supported by the American Academy of Pediatrics and the University of Michigan
Health System. Both of these associations conduct research of their own. Each of the
articles that were reviewed and cited contained specific information about adverse reactions
of medications, growth and development of infants, information about the FDA and drug
development, and specific medications.
The discovery of research began with searching for articles that contained
information regarding long term effects of prescription medication on infant development.
When no articles were found containing such information, the search was refocused on
discovering the possible impact the most commonly used drugs could have on development.
First, articles discussing the most commonly used drugs in Neonatal Intensive Care Units
were gathered and analyzed to create a category. Next, articles detailing all known side
effects of those drugs were gathered and analyzed, creating a new category. Finally, the third
category was created with information about typical infant development in the first six
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months of life. This category was created in order to apply short term side effects to the first
six months of development. From there, hypotheses could be made regarding long- term
effects of these medications on growth and development.
Data Analysis
Data was collected through literature review. The literature review began with an
internet search for long-term effects of prescription medications given to infants. After
searching with multiple key words and no articles matching the criteria, it was determined
that no information meeting the criteria exists. Given that no information could be found,
research questions were refocused in order to determine from current information, the
physiological, short-term side effects of the drugs, and identify relationships to their impact
on development. Data was triangulated by using multiple sources of information, through
extensive review of the research.
Data was analyzed using a constant comparative method (Glaser & Strauss, 1967).
Units of analysis were defined. As data was collected, it was recorded, classified and
compared across categories. Relationships across categories were identified. The first unit
of analysis was defined as the names of drugs administered to infants. From that unit of
analysis categories of the most commonly used drugs were identified. The second unit of
analysis was defined as short-term side effects of the most commonly used drugs. The third
unit of analysis was defined as developmental milestones during the first six months of life.
These categories provided a framework for aligning the physiological effects of those drugs
with physical, cognitive, and social-emotional domains of development.
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The most commonly used drugs were identified by the frequency of specific drug
names in conjunction with its use in NICUs in the literature. Each time a specific medication
was mentioned, it was tallied. Additionally, several medications were mentioned in articles
as being the most “commonly used” analgesic or sedative. After reviewing the literature and
medication names, the medications most frequently mentioned were chosen for this study.
The medications that were discussed most often were morphine, fentanyl, lorazepam,
midazolam, Phenobarbital, ketamine, ibuprofen, and acetaminophen.
Once the most commonly used drugs were determined, the most common side effects
were identified. A table was created with each drug and listed the known side-effects. The
side-effect was marked each time it appeared in the literature. Again, the side effects with
the most tallies were the side effects deemed most common. Side effects that were
mentioned in one article or referred to in extreme cases were not considered common.
Additionally, the most common side-effects were tracked and recorded in order to generalize
potential long-term effects of prescription drugs.
In order to correlate potential side effects of medications to stages of development,
developmental milestones were identified. The time frame for development was focused on
the first six months of life. The reason for the time frame was based on exposure to
medication occurring shortly after birth. Most likely, typical development would be delayed
or interrupted during first six months due to hospitalization, therefore making the first six
months of development the most effected time period of development. Research was
reviewed from credible sources such as the University of Michigan and the American
Academy of Pediatrics. After identifying physical, cognitive, and social-emotional
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developmental milestones another table was created highlighting typical development. After
researching developmental milestones, the short-term side effects were applied to stages of
development. As the short-term side effects were applied, generalizations were made
regarding potential long-term effects.
Upon researching short term side effects of the most commonly used drugs and stages
of development, connections became apparent. Many of the short term side effects interrupt
the process of typical development. If typical development is interrupted, then infants most
likely would not meet developmental milestones as expected. Once connections could be
made between known short term side effects and infant development, potential long term side
effects could be predicted. From all of the research and connections that were made,
ultimately, more questions arose.
Summary
The goal of this study was to determine the long-term effects of exposure to
prescription medication on infant development. After searching for information, with no
success, the study was refocused. In order to infer long-term effects, short-term effects of the
most commonly used drugs were applied to development in the first six months of life. Data
for this study was collected through an extensive literature review. The data collected and
analyzed was in the categories of most commonly used drugs, their side effects, and typical
development in the first six months of life.
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Chapter Four: Results
This chapter begins with an explanation of the context of the study. Once the context
of the study has been stated, the chapter moves on to discuss the findings of the study.
Included in the findings are areas that need further study. Finally, the chapter concludes with
a summary.
Context
The context for this study is research literature. Data was gathered through the use of
the internet use of the internet for articles listed in medical databases that contain peer
reviewed journal articles. Documentary research was the best choice for this study based on
the fact that actual field work could take decades to determine long-term effects of
prescription drugs.
Findings
The findings in this study are based on some very interesting data as well as
implications for further study. The main question, the question that this study stemmed from,
what are the long-term effects of exposure to prescription drugs during infancy? According
to a review of the literature, the only effects that have been studied and documented are all
short-term effects. Based on analysis of the data, the most commonly used analgesics and
sedatives used in Neonatal Intensive Care Units can be classified as opioids,
benzodiazepines, barbiturates, and non-steroidal anti-inflammatory drugs. Each category has
its own drugs of choice for use in the NICU. The most commonly used opioids are morphine
and fentanyl. Benzodiazepines most commonly used are midazolam and lorazepam.
Phenobarbital is the most commonly used barbiturate. NSAIDs have two commonly used
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medications ibuprofen, and acetaminophen. There is one other commonly used drug that
does not fit into any of the categories. Ketamine is also used commonly used in NICUs.
Table 1 contains the most common medications used in the NICU and their known side
effects.
Table 1
Drug Name
Opioids
Morphine

Fentanyl

Common Side Effects
nausea, vomiting, constipation,
lightheadedness, dizziness,
sedation, sweating, dysphoria,
euphoria, dry mouth, respiratory
depression, gastrointestinal
depression and rash
nausea, vomiting, constipation,
lightheadedness, dizziness,
sedation, sweating, dysphoira,
euphoria, dry mouth, respiratory
depression, and tolerance

Benzodiazepines
Midazolam
myoclonic jerking, respiratory
depression, excessive sedation, and
hypotension
Lorazepam

Barbiturates
Phenobarbital

myoclonic jerking, respiratory
depression, excessive sedation, and
hypotension
sedation, depression, insomnia, and
altered mood or behavior. In
addition to the above side effects,
there is the chance of physical
dependence and severe adverse
reactions with many other
commonly used drugs

NSAIDs
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Acetaminophen

Rare side effects only, very few
interactions with other medications
reported.

Ibuprofen

nausea, diarrhea, headache,
dizziness, fluid retention, elevated
blood pressure, gastrointestinal
ulceration, and bleeding

Other Drugs
Ketamine

raise blood pressure and pulse rate,
raise intracranial and intraocular
pressure, hypersalivation, increase
muscle tone, in some cases alter
mood and behavior

Based on the most common side-effects, the following table (Table 2) was created to
illustrate the most common side-effects of the most commonly used medications. From that
information, generalizations about the impact side-effects have on growth and development
are presented.
Table 2
Drug Name

Morphine
Fentanyl
Midazolam
Lorazepam
Phenobarbital
Acetaminophen
Ibuprofen
Ketamine

Nausea/
Vomiting

Diarrhea or
Constipation

Dizziness

X
X

X
X

X
X

Alteration
of blood
pressure

Physical
Dependence

Respiratory
Depression

X

X
X
X
X

X
X
X
X

X

X
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X
X

Some of the most common short-term side effects do not seem detrimental, as they
should be short lived. However, imagine an infant, at a time that is critical for growth and
development, experiencing these side-effects. An infant who should be eating, sleeping,
exploring, and growing, may not feel pain, but would experience side effects that could leave
lasting impressions. Many of the side effects could impact nutrition and overall growth of an
infant. An infant who feels nauseous or is vomiting would most likely have little interest in
food. This could impact growth and nutrition for longer than the duration of use of the
medication. Additionally, if an infant is suffering from diarrhea or constipation, they would
also most likely not be willing to eat.
Furthermore, when medical professionals are assessing the pain level of an infant
they check vital signs. One of the most significant vital signs in assessing pain is blood
pressure. Four of the most commonly used medications could either raise or lower blood
pressure. This is significant when considering long-term effects of medication. If an infant’s
blood pressure is lowered by a side-effect of a drug then their pain may be under treated and
therefore they will suffer long-term effects of exposure to pain. Pain receptors in the brain
could be permanently altered, ultimately changing the way an infant responds to pain in the
future. Conversely, if an infant’s blood pressure is raised due to a side-effect of a drug then
they may be over medicated. Again, no longitudinal studies were found regarding long-term
effects of these medications. However, too much of a drug cannot be beneficial. In order to
reduce drug-induced side effects and the unknown long term side effects, the amount and
length of time exposed to medications should be limited (Rosen & Dower, 2011). Another
potential long-term effect is physical dependence which could ultimately lead to addiction.
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Addiction is a life-long affliction and could be considered a long-term effect of exposure to
prescription drugs.
After researching and analyzing the effects prescription drugs have been found to
have on adults, generalizations were made as to their effects on infants and their
development. Table 3 offers a description of typical development and ways to support
development if certain milestones are not met. As always, parents or caregivers should
consult a physician if they suspect a delay of any kind.
Table 3

Age

Developmental
Milestones

Activities to Promote
Development

Jerky motions with arms
and legs

Allow infant to move freely.
Encourage movement on the floor
or play mat.
Assist infant by moving hands
towards face and away again.

Physical
Development
One Month

Move hands towards eyes
and mouth

Three Months

Move head side to side

Allow infant to move on back and
belly. Encourage movement by
moving toys from one side of their
head to the other.

Smoother Motions with
arms and legs

Allow infant to move freely.
Encourage movement on the floor
or play mat.

Lift head when held
upright

Hold infant upright, allowing them
to build strength.

Lift head and chest when
on stomach

Provide tummy time several times
a day.

Track objects or people
with eyes

Encourage movement and tracking
by moving toys into and out of the
infant's field of vision.
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Six Months

Cognitive
Development
One Month
Three Months

Hold head steadily

Hold infant upright, allowing them
to build strength.

Rolls over

Provide tummy time often.
Encourage rolling over by placing
toys on either side of the infant,
just out of reach.

Sits with assistance

Help infant to a sitting position and
offer support, allowing infant to
balance on their own as much as
possible.

Reaches for objects

Encourage reaching in any position
by placing objects just out of
reach. When infant is lying down,
dangle objects over them.

Transfers objects from
hand to hand

Model and assist infant by placing
objects in one of their hands and
transfer to the other hand for them.

Bangs objects together

Model and assist infant by placing
an object in each hand and clap
them together.

Recognizes sounds and
may turn in that direction

Talk, sing, read, or make noises to
the infant.

Turn toward familiar
sounds

Turn toward bright colors
or light

Again, talking, singing, reading, or
making noise will encourage the
infant to turn toward familiar
sounds.
Offer toys with bright colors and
contrasting patterns.

Respond to noise like a
rattle

Play with the infant by using toys
that make noise.

Six Months
Open mouth for spoon
Imitate familiar actions of
caretakers
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Be consistent with feeding solid
foods, this will develop familiarity.
Talk to infants as tasks are
completed, label actions. Include
infant in everyday actions like
cleaning or cooking.

Social-Emotional
Development
One Month

Study faces

Spend time face-to-face with
infant, this will encourage eye
contact and studying of facial
features.
Be gentle when handling infants.
Provide toys and blankets that are
soft to the touch.

Prefer soft touches

Three Months

Respond to familiar voices
and sounds

Talk, sing, read, make noises, and
repeat sounds infant makes.

Calms easily

Encourage self-soothing methods
such as pacifier, finger or thumb
sucking. Hold the infant and speak
softly.

Coo or gurgle
Cry to communicate needs
Smile in response to others

Six Months

Talk, sing, make noises, and repeat
any sounds infant makes.
Respond promptly to infant's cries.
Smile when interacting with an
infant. Be sure to smile in
response to an infant's smile.

Babbles

Encourage infant to make sounds
by responding and mimicking
sounds they make.

Recognize familiar faces

Be sure to make eye contact with
infant when interacting. Name
familiar people as they hold or
play with the infant.

Smile at self in mirror

Allow and encourage infant to play
with toys that have mirrors. Show
them their reflection and talk about
who is in the mirror.

Is able to scream, laugh,
and squeal

Interacting with and responding to
an infant will promote screaming,
laughing, and squealing.
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Table 3 is divided into three areas of development, physical, cognitive, and socialemotional. Each of the three areas is then sectioned into ages, one month, three months, and
six months. There are developmental milestones listed for each age range in all three areas
of development. Table 3 is meant to illustrate the timeline of a typically developing infant.
The final column provides activities and ideas to further development. Infants who have
been hospitalized may not meet developmental milestones when expected. The objective of
Table 3 is to provide assistance in understanding typical development.
Effects of Physical Development
If infants are hospitalized and essentially immobile, they are unable to develop motor
skills at the typical rate. In the first month of life a typically developing infant is able to
make jerky motions with arms, move hands close to eyes and mouth, and can move head
from side to side when lying on stomach (American Academy of Pediatrics, 2013). At three
months of life an infant who is typically developing can move with smoother motions, lift
head when held upright, lift head and chest when on stomach, hold a toy that is presented,
track an object or person with their eyes, and hands are no longer in fists, they are more
relaxed (National Network for Child Care [NNCC], n.d.). And, by six months a typically
developing infant should be doing all of the above in addition to, holding head steadily on
own, reaching for objects, playing with their toes, transfer toys from hand to hand, shake and
bang toys, rolling over, and sitting with minimal help (National Network for Child Care
[NNCC], n.d.). All of the motor skills build on each other.
An infant who has been sedated and immobile has missed crucial time in developing
motor skills. Any and all movement during infancy is assisting in the acquisition of motor
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skills. Even at one month of age an infant should be moving their arms and legs, move hands
towards their face, and move their head when lying on their stomach. Imagine an infant who
is sedated and lying on their back, immobile. How could an infant then develop motor skills?
Additionally, if an infant has not had tummy time or the opportunity to move at all they will
have gross motor delays. For example, if an infant is delayed in rolling over, they may also
be delayed in sitting as sitting up on their own is developed after they learn to roll over.
Long-term, an infant who has gross motor delays may always have delays or difficulty with
coordination. In terms of fine motor skills, infants need to manipulate objects to acquire fine
motor skills. Infants who are delayed in developing fine motor skills could face difficulty
with coloring, writing, zipping, or tying in the future. It seems that motor delays could be
resolved with appropriate interventions.
In addition, common side effects of the most popular drugs include gastrointestinal
issues, nausea, and diarrhea. How is an infant supposed to grow and have energy if they are
experiencing adverse reactions to the drugs that helped them heal? According to the
research, the majority of side effects are short term and reversible. However, side effects that
affect the gastrointestinal system (GI system) may leave lingering side effects. Morphine has
been studied more than any other drug mentioned. One of the known side effects of
morphine is its effect on the gastrointestinal system. In multiple studies, morphine has
shown to alter the motility of the GI system (Walter-Nicolet et al., 2010). So, if an infant’s
GI motility has been slowed by the effects of morphine, they are not going to eat like a
typical infant would. This could affect the growth of the infant. Also, if an infant is not
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eating and growing as they should, they may not have the energy or endurance needed to
explore and move about their environment.
Effects on Cognitive Development
How would a delay in cognitive development affect a child’s long-term development?
If an infant is sedated even for the first month of life, that is a significant amount of time that
is lost. An infant who is sedated is not able to study faces of family members, or connect
their voice to their faces. This may cause disconnect in the relationship between the infant
and parents. In addition, the hospital is a bright and noisy place. Given that six month old
infants should respond to both visual and auditory stimuli, could the hospital setting
desensitize infants? Or, could the bright and loud hospital setting cause overstimulation?
Either could lead to long-term effects, such as not responding appropriately to loud noises
like sirens or alarms. Conversely, being too sensitive to sound could cause misbehavior or
fear of loud noise. In terms of the brightness, potentially infants exposed to the hospital
environment may not be able to sleep normally as they have grown accustomed to the
brightness all day. To determine long-term effects of medication would be difficult to
determine, as effects from the hospital stay and sedation itself would be difficult to
extrapolate from each other.
Additionally, many drugs have the potential to create physical dependency.
Addiction affects the brain in very specific ways. How would addiction alter an infant’s
brain development? There is little research to answer this question. The majority of research
involving addiction refers to adult addiction habits or risk factors for addiction.
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Effects on Social-Emotional Development
With the limited interactions that sedatives and other drugs create, social- emotional
development is deeply impacted. “Relationships are the way babies come to know the world
and their place in it. They provide the loving context necessary to comfort, protect,
encourage, and offer a buffer against stressful times” (Zero to Three: National Center for
Infants, Toddlers, and Families, 2012, para. 1). Infants, who are unable to interact, would be
unable to establish relationships, which is the cornerstone of social-emotional development.
By one month of age, a typically developing infant is expected to recognize and respond to
voices, study faces, and prefer soft touches. An infant who is sedated or in pain would either
miss those experiences completely or the experience could be overridden by pain. As an
infant develops, they are making connections, if they are in pain when someone touches
them, they may associate pain with touch, therefore not wanting to be touched or possibly
held. Also, as previously stated, if an infant is unable to study faces, they may be unable to
recognize their parents, therefore potentially adversely affecting the parent-child relationship.
As with other forms of development, social-emotional development builds skill upon skill.
By three months of age, a typically developing infant is able to communicate through cooing,
crying, or expression (Zero to Three: National Center for Infants, Toddlers, and Families,
2012). An infant, who has been sedated, may not have had the opportunity to learn to cry to
elicit a response from caregivers. Also, if they do cry, they may not know what it is like to
be comforted. Again, this is something that could adversely affect the parent-child
relationship. Parents are supposed to be the primary caregivers, the ones who protect a child
from harm. What happens when an infant is hospitalized from birth and bonding is delayed
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several weeks or months? All in all, in infancy social-emotional and cognitive developments
are closely related and rely on interactions, which may not happen when an infant is
hospitalized.
Effects on Overall Health
Upon release from the hospital, it is assumed that the patient is given a clean bill of
health. However, after enduring painful procedures and multiple drugs, there may still be
struggles ahead. Again, many of the drugs used as analgesics and sedatives have common
side effects such as nausea, diarrhea, respiratory depression and various effects on the GI
system. Many of the side effects could affect the infant’s ability to eat normally. “Morphine
analgesia delays the initiation and attainment of full enteral feeding” (Walter-Nicolet et al.,
2010, p. 358). Although most of the side effects are said to be short term, they could alter the
eating and sleeping habits of an impressionable infant. Infants should be able to suck,
swallow, and breathe naturally as they eat. However, infants who have been hospitalized
may not have developed that skill which is compounded by the side effects of the drugs. So,
if an infant is not eating as they should, they are not consuming enough calories, which in
turn mean they are not growing as they should. Therefore, nutrition is effected as well as the
overall health of the infant. In addition, infants who have been hospitalized have been
accustomed to a bright environment where people are around all of the time. There is no
differentiation between night and day. Sleep patterns are also important for overall health
and growth. There are rare instances where some drugs have been known to cause insomnia.
All of these issues become intertwined when discussing development of an infant. And
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again, it is difficult to know where the side-effects of the drugs and the side-effects of the
hospitalization separate.
With all of the research detailing short-term effects of pain and sedation medications,
one would think the same would be true for long-term effects. However, given the cost and
time to conduct such studies, it appears that the medical community will continue to use
these medications “off-label” for pediatric patients. This is a concern, as it is important to
know both short and long-term effects. Knowing effects of medications would assist in
preparation for the impact on development. And, being prepared could eliminate or
significantly reduce developmental delays created by the side effects of prescription drugs.
Therefore, studies should be conducted to determine long-term effects of medication.
Such studies should be conducted in the medical and educational fields. Although
these studies have yet to be conducted, generalizations can be made regarding long term
effects. Many of the known common short term side effects involve the gastrointestinal
system, nausea, vomiting, and diarrhea. All of those side effects could impact the desire to
eat. If an infant is feeling these symptoms, they may be reluctant to eat. If an infant does not
eat, they do not have energy or grow. Additionally, respiratory depression is a short term
side effect of several drugs. A child who is not breathing well is not able to eat well. Again,
this creates poor eating habits and poor growth. Poor eating habits and slow growth could be
long term effects. Long term effects on physical development could be impacted by poor
growth. Physical development could also be impacted in the form of coordination, balance,
and strength. Cognitive and social-emotional developments both involve communication and
relationships. Long term effects from sedation could include creating and maintaining
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relationships, as well as communication in general. Knowing what to expect in terms of
long-term effects would allow for doctors, families, and educators to take preventative
measures to ensure the success of the child. As needed as these studies are, they could be
difficult to complete. Some of the long-term side effects that could be attributed to early
exposure to medication could also be attributed to a diagnosis or hospitalization. Perhaps
this is part of the reason for lack of research in this area.
Several trends, patterns, and gaps were found through the research literature review.
Upon completing research, drugs most commonly used in NICUs were identified. The most
commonly used drugs were determined to be morphine, fentanyl, midazolam, lorazepam,
Phenobarbital, ketamine, acetaminophen, and ibuprofen. From the research of specific
medications, similar side effects became apparent. The majority of the common side effects
involve gastrointestinal issues like nausea, vomiting, and diarrhea. Other common side
effects include dizziness and headache. One of the most concerning side effects that
emerged is the possibility of physical dependence. The most obvious trend identified was the
fact that the most common side effects are short term, no long term side effects have been
identified. This trend presents a major gap in research as well.
Summary
This study was conducted through extensive literature review rather than in the field
due to time constraints. There was an abundance of research regarding use of medications
for pain management and sedation in adult patients. However, research regarding the use of
the same medications for infants is limited and longitudinal studies do not seem to exist yet.
Through the use of information gathered about side-effects of the most commonly used
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medications generalizations have been made about what long-term effects could be caused by
early exposure to prescription medication. Finally, the growth and development of a
typically developing infant is detailed and accompanied by suggestions for promoting
development. Given the lack of research regarding long-term effects of prescription
medication, further studies are necessary. Ultimately, the findings in this study led to more
questions and the need for further study.
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Chapter Five: Conclusion
Summary of the Study
Expectant parents are excited for the arrival of their baby. However, there are times
when excitement is replaced with other emotions as hospital stays are sometimes necessary
for newborns. There are a number of reasons as to why an infant could be hospitalized.
During that stay an infant could be exposed to a number of medications. How does exposure
to prescription drugs in infancy affect growth and development? This is the question that
drove this study.
In order to attempt to discover what the long-term effects of exposure to prescription
medications are documentary research was conducted. In addition to the original research
question regarding long-term effects of prescription medication, several other questions
arose. Other areas that were researched include narrowing the medication list to the most
commonly used pain and sedation medications in Neonatal Intensive Care Units. From that
list, a review of medical journal articles containing known side effects of each drug was
conducted and common side effects were determined. Also the impact of side effects on
physical, cognitive, and social-emotional development were considered and researched.
Ultimately, the extensive literature review revealed more questions and areas for further
study.
At the conclusion of this study, again more questions remained. There is no true
answer to what the long-term effects of prescription medications are. Instead what was
discovered was that short-term effects are known and have been researched on adults, not
pediatric patients. Additionally, the Food and Drug Administration has created regulations
49

that are in the best interest of pediatric drug use. However, even with the regulations, doctors
still have flexibility in prescribing and using drugs that are not approved for pediatric use by
using them “off-label” (Luo et al., 2007). The question of long-term effects still remains. In
order to generalize what the long-term effects could be, typical development was discussed
along with delays or complications in development. The most significant finding is that the
medical community has studied short term side effects of these medications, but long term
side effects have not been studied. Therefore, the greatest conclusion that can be made is that
there is a need for further study.
Conclusion
Although the research did not conclusively answer the question of long-term effects
of prescription medication, there are many conclusions that can be made. One of the most
significant conclusions that can be drawn from the research is that perhaps the medical
community does not see a need for further study in this area. In terms of surgery or a
medical diagnosis, medical staff is only concerned with saving a life. Once a patient has
been discharged from the NICU, they may not see the surgeons, doctors, and nurses that are
responsible for saving their life. Therefore, those same surgeons, doctors, and nurses are not
the medical staff who would have the opportunity to observe long-term effects of
medications. Along the same lines, the medical community is known to use drugs “off-label”
and can see their immediate effects. So, why be concerned about long-term effects when the
infant is surviving?
The Food and Drug Administration has created regulations in an attempt to protect
pediatric patients. However, those same regulations make it possible for medical
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professionals to use drugs “off-label” as they see fit. And, the process to label drugs for
pediatric use is extensive and costly. So, why study long-term effects when drugs can be
used “off-label” and help save lives?
Armed with the knowledge of adverse effects of both exposures to pain versus the
side effects of analgesics, the research indicates that medication wins. Given that exposure to
pain could alter neurological pathways, the side effects of some drugs seem to make less of a
permanent impact but a great short term solution. There is clear evidence that early exposure
to pain can be more detrimental to the development of an infant than some of the side effects
of the medications. If an infant is exposed to pain, especially during critical developmental
times, then the pathways in the brain that recognize pain could be altered permanently. With
that said, it then becomes even more obvious that there is a need for longitudinal studies on
the long-term effects of prescription medication.
As a child grows and develops, they are expected to meet certain milestones along the
way. Children who have been exposed to medications during infancy could suffer long term
effects. During a hospital stay, an infant who is sedated is not moving, and therefore not
developing. As discussed previously, there are critical times for development. How does
early exposure to prescription medications effect development? As discussed previously,
there are critical times for development. Could lack of movement in infancy lead to poor
muscle tone and lack of strength later on? Could lack of movement in infancy lead to poor
muscle tone and lack of strength later on? Even with interventions some children may not
develop and develop a delay places them further and further behind their typically
developing peers. Also, if a child is not developing at a typical rate and lacks strength, they
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may also lack appropriate balance and coordination. In regards to fine motor development,
without the opportunity to open their hands and manipulate objects could have fine motor
difficulties which impact writing, coloring, drawing, and dressing themselves. Also, without
the movement of their hands, a child may not develop effective hand-eye coordination.
Additionally, due to delays in growth from a hospital stay and potential side effects from
medication, a child who has been exposed to analgesics and sedatives may be shorter and
thinner than their peers. This could be due to side effects that medications have on the GI
system or the fact that eating habits could be impacted as well. All in all, the physical
development of children who have been exposed to prescription drugs during infancy could
be impacted for many years.
How would a delay in cognitive development affect a child’s long-term development?
An infant who is sedated is not able to study faces of family members, or connect their voice
to their faces. This may cause disconnect in the relationship between the infant and parents.
Can this potential disconnect or lack of bonding be reversed? How would this impact the
development of a parent-child relationship? Also, how would this disconnect affect the
development of other relationships? In addition, the hospital is a bright and noisy place.
Given that six month old infants should respond to both visual and auditory stimuli, could the
hospital setting desensitize infants? Or, could the bright and loud hospital setting cause over
stimulation? Either could lead to long-term effects, such as not responding appropriately to
loud noises like sirens or alarms. Conversely, being too sensitive to sound could cause
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misbehavior or fear of loud noise. In terms of the brightness, potentially infants exposed to
the hospital environment may not be able to sleep normally as they have grown accustomed
to the brightness all day.
Social-emotional development can be greatly impacted by the use of analgesics and
sedatives. Infants who are medicated would be unable to interact and therefore unable to
establish relationships, which is the base of social-emotional development. Typically
developing infants are expected to recognize and respond to voices, study faces, and prefer
soft touches by one month of age. An infant who is sedated or in pain would either miss
those experiences completely or the experience could be overridden by pain. As an infant
develops, they are making connections, if they are in pain when someone touches them, they
may associate pain with touch, therefore not wanting to be touched or possibly held. Also, as
previously stated, if an infant is unable to study faces, they may be unable to recognize their
parents, therefore potentially adversely affecting the parent-child relationship. As with other
forms of development, social-emotional development builds skill upon skill. By three
months of age, an infant should be communicating through cooing, crying, or expression
(Zero to Three: National Center for Infants, Toddlers, and Families, 2012). An infant, who
has been sedated, may not have had the opportunity to learn to cry to elicit a response from
caregivers. Also, if they do cry, they may not know what it is like to be comforted. Again,
this is something that could adversely affect the parent-child relationship. Parents are
supposed to be the primary caregivers, the ones who protect a child from harm. What
happens when an infant is hospitalized from birth and bonding is delayed several weeks or
months?
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Suggestions for Promoting Development
Development of an infant can be broken into the three categories of physical,
cognitive, and social-emotional development. However, in terms of fostering development,
many of the activities overlap and intertwine. The basic premise for infant development is to
interact and play with them. As previously stated, cognitive and social-emotional
development hinge on interaction. This is difficult to do when an infant is discomforted or
sedated. However, most infants have fully developed hearing, so talking, humming, or
singing can be a great way to connect with an infant who is sedated. Additionally, touch is
important. Parents can still touch their infant as they are talking to them to help facilitate a
relationship. It is not always possible to hold an infant who is hospitalized, but that would be
best if possible. Simply holding an infant helps develop motor, cognitive, and socialemotional skills all at the same time. While in the hospital, there is typically a support
system known as the Child Life Specialists. They are in place to assist in keeping infants
comfortable, promotion of development, and fostering parent-child relationships. Child Life
Specialists are a great resource while an infant is in the hospital (Regents of the University of
Michigan, 2013).
How can parents support development after discharge? Again, interacting and
playing with an infant is the best way to promote development. Also, talking to an infant
using various tones and making eye contact will stimulate social-emotional and cognitive
development. Reading, singing, and telling stories will also foster cognitive and socialemotional growth. As an infant grows, they begin to coo and make sounds. Repeating the
sounds or words an infant makes will also assist in their development. Promoting motor
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development involves encouraging an infant to explore and manipulate objects. Parents can
model and encourage touching, banging, stacking, and shaking of toys. Also, tummy time is
extremely important in the development of motor skills. Spending time on the floor with an
infant will help them develop motor skills.
There are resources for parents who have concerns about the growth and development
of their child. All states have early childhood programs of one sort or another. Infants with
developmental delays could receive occupational therapy, physical therapy, and speech
therapy based on their needs. Additionally, maintaining contact with an infant’s pediatrician
or family doctor is crucial in assuring that a child with a delay is receiving all they need to
grow and develop.
Recommendations
Given the lack of longitudinal studies on the long-term effects of medications on the
growth and development of an infant, the first recommendation would be to conduct
longitudinal studies. There are many known short-term side effects of medications that could
alter development and behaviors. Additionally, the long-term effects of early exposure to
pain are known and well documented. The same should be true for long-term effects of
medications. There is a significant need for longitudinal studies that not only determine
long-term effects on health, but also overall development. From these studies, programs
could be developed to assist families foster the growth and development of their child.
The need for longitudinal studies is apparent. Such studies should be conducted in
both the medical and educational fields. From a medical standpoint, studies need to be
conducted to determine effects on growth and development. Any side effects that could be
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avoided or corrected as soon as possible would be the ultimate goal of medical studies.
Educational studies, on the other hand, would target how developmental delays and/or
medical issues affect a child’s ability to learn and function in a classroom environment. In
order for these types of studies to become a reality, the medical and educational communities
would need to collaborate.
In order for longitudinal studies to be conducted the Food and Drug
Administration will need to be involved. Although there are some regulations regarding
labeling medications for pediatric use, there are areas for improvement. Currently, drugs
approved for pediatric use must go through a rigorous approval process which includes
conducting studies on pediatric participants. However, there are ways around the extensive,
costly process. Companies can get their drug approved for “off-label” use and therefore, they
do not have to comply with FDA regulations if there is a need for a medication. An example
of such medication would be morphine. Morphine has been studied extensively on adult
patients and a need has been shown for use in pediatric patients. Given that information, the
FDA should alter their regulations and make it mandatory that all medications given to
pediatric patients have a pediatric label.
Ultimately, this study has shown that there is a gap in the research regarding longterm effects of early exposure to prescription medications. Given that there is such a gap in
knowledge, there is a need for further study. Longitudinal studies should be conducted in the
medical and educational fields to truly assess the long-term effects of medications. For now,
known short-term side effects can be used to hypothesize potential long-term side effects.
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